Understanding Infundibulo-neurohypophysitis (INH)

Infundibulo-neurohypophysitis (INH) is a rare inflammatory condition that affects specific parts of the brain’s control center for hormones. It is an anatomical subset of a broader group of conditions called hypophysitis, which refers to any inflammation of the pituitary gland ^[1][2]. Because it targets the area responsible for water balance, the most common symptom is intense thirst and frequent urination, a condition now called arginine vasopressin deficiency (AVP-D), formerly known as central diabetes insipidus ^[3][4].

Anatomy and Classification

To understand INH, it helps to view the pituitary gland and its connection to the brain in distinct parts:

• The Hypothalamus: This area of the brain actually produces the hormone vasopressin (which controls water retention).
• The Infundibulum (Pituitary Stalk): This is the bridge connecting the brain (hypothalamus) to the pituitary gland, serving as the pathway for the hormone.
• The Neurohypophysis (Posterior Pituitary): This is the back part of the gland where vasopressin is stored and released into the blood ^[2].

In INH, the inflammation is predominantly localized to these “posterior” structures and the stalk ^[1]. This is different from adenohypophysitis, which affects the front part of the gland (anterior pituitary) where most other hormones are made, or panhypophysitis, which involves the entire gland ^[5]. While INH focuses on the back part, doctors still monitor the front part because hormone deficiencies there can sometimes develop later, and broader systemic disease can coexist ^[6].

Autoimmune Mechanisms and Triggers

The most frequent form of this condition is lymphocytic infundibulo-neurohypophysitis (LINH), which is considered an autoimmune disease. In this version, your immune system mistakenly attacks its own tissues ^[7].

Researchers have identified a specific target of this attack called Rabphilin-3A, a protein found in the neurons that produce vasopressin ^[3].

• Antibodies: Many patients with LINH (approximately 76% in one small study) have anti-Rabphilin-3A antibodies in their blood ^[8]. While testing for these can help support a diagnosis, it is a research-grade test with limited availability. A positive result is not independently diagnostic because these antibodies can occasionally appear in other conditions like certain tumors or sarcoidosis, and a negative result does not exclude INH ^[9][10].
• Secondary Triggers: While many cases are “primary” (occurring on their own), INH patterns have been reported in association with immune checkpoint inhibitors (a type of cancer immunotherapy) or certain viral infections like Epstein-Barr virus ^[11][12]. These are reported associations in select cases rather than proven universal causes.

Who is Affected?

INH is a rare condition, and because it is so uncommon, most of what we know comes from small groups of patients rather than large population studies ^[5].

• Demographics: It can affect people of any age. It has been documented in children as young as 3 years old and in adults ^[6][2].
• Pregnancy and Postpartum: There is a known association with the late stages of pregnancy and the first year after delivery (postpartum). In some cases, the symptoms of thirst and urination begin during the third trimester and persist after the baby is born ^[13][14].

Diagnosis and MRI Findings

Diagnosing INH is often a process of exclusion because many different things can cause the pituitary stalk to look “thick” on a scan ^[15]. Doctors typically look for:

1. Stalk Thickening: On a contrast-enhanced MRI, the pituitary stalk may appear wider than normal ^[16]. While some studies mention a threshold of 6.5–7 mm as a point where doctors may consider biopsy, this is not a universal decision rule; the decision depends on age, growth rate, and symptoms ^[6][15].
2. Loss of the “Bright Spot”: Normally, the stored vasopressin in the back of the pituitary gland shows up as a bright spot on certain MRI sequences. In INH, this bright spot often disappears ^[16]. However, this is a supportive, nonspecific finding. Its absence does not prove complete AVP-D, and it can occasionally be absent in healthy people.
3. Biochemical Confirmation: Blood and urine tests (sometimes including a copeptin test) are used to confirm that your body is not producing enough vasopressin ^[17][18].

Because a biopsy of the pituitary stalk is a delicate and risky procedure, a multidisciplinary team often prefers to monitor the area with repeat MRIs every few months ^[19]. If the stalk thickening stays the same or shrinks over time, it supports a diagnosis of INH. If it grows, the care team may need to investigate other causes, such as a germinoma (a type of tumor) or Langerhans cell histiocytosis ^[20][21].

While the physical thickening of the stalk often improves or resolves on its own within months, the hormonal deficiency (the thirst and urination) often requires long-term management with desmopressin, a medication that replaces the missing vasopressin hormone ^[6][16].